The Early Development Leader (EDL) at GSK is a strategic role responsible for leading a medicine's development from Lead Optimization through Proof of Concept. This includes establishing the development strategy, providing matrix leadership to the Early Development Team (EDT), and managing stakeholders across R&D, Commercial, and Medical.